Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Bayer AG BAYRY announced that the first patient has been enrolled in the late-stage SOHO-02 study on pipeline candidate BAY ...

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in ...

Crestone Pharmaceuticals recently shared topline results from a phase 2 trial of its investigational drug treatment for ...

Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

BCL2 is an important regulatory protein of apoptosis pathway, and its abnormal expression is related to the development of various hematologic malignancies. ICP-248 is a novel, orally bioavailable ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals (NASDAQ: VNDA). The commercial-stage ...

Dato-DXd is an engineered TROP2-directed DXd antibody-drug conjugate discovered by Daiichi Sankyo Ltd DSKYF DSNKY and being jointly developed by AstraZeneca and Daiichi Sankyo. In the overall ...

Shares of Wockhardt are locked at upper circuit after the pharma company said on September 19 that one of its investigational drug - Zaynich - has successfully treated critically ill patients of ...

Genmab A/S (Nasdaq: GMAB) announced today new data from the Phase 1/2 study of rinatabart sesutecan (Rina-S), an investigational folate receptor-alpha ...

Phase I data presented at ESMO suggested that TORL-1-23 may have particularly strong activity in CLDN-positive advanced ...